PubMed · 2013 · 15 citations · 26 references
MedicineOncologyPharmacologyApoptosisChemotherapyMolecular OncologyApoptosis In CancerApoptosis PharmacologyCytotoxic ChemotherapyMelanoma PharmacotherapyMolecular Mechanisms Of ToxicityPharmacodynamics Of Anticancer AgentsAnthracycline-based ChemotherapyAnticancer ActivityApoptosis Signaling In CancerAtp-binding Cassette TransportersChemotherapy-induced ApoptosisCombination Drug TherapyNf-κb SignalingPoly(adp-ribose) Polymerase Inhibition
BACKGROUND: Melanoma is characterized by high resistance to chemotherapy. The aim of this study was to investigate combined effects of doxorubicin and parthenolide on melanoma cells. MATERIALS AND METHODS: Thiazolyl blue tetrazolium bromide (MTT) assay and flow cytometry were used to evaluate viability. The p53 levels and Poly-ADP ribose polymerase (PARP) cleavage were assessed by western blot. Electrophoretic mobility shift assay (EMSA) and quantitative real-time polymerase chain reaction (qRT-PCR) were used to evaluate changes in nuclear factor-κB (NF-κB) activity and gene expression, respectively. RESULTS: Both drugs reduced the viability of melanoma cells and induced apoptosis. Expression of the ATP-binding cassette sub-family B member-5 (ABCB5) transporter was enhanced by doxorubicin. Doxorubicin induced activity of p53 and NF-κB. Parthenolide markedly reduced the constitutive and doxorubicin-induced NF-κB activity measured as the nuclear NF-κB, and expression of matrix metalloproteinase-9 (MMP9) and it had no effect on p53. DISCUSSION: Doxorubicin and parthenolide affected distinct pathways in melanoma, and parthenolide was capable of combating some pro-survival effects of doxorubicin in the combined treatment. This provides a rationale for in vivo investigation of this drug combination.
26
Transcriptional Cross Talk between NF-κB and p53
Gill Webster, Neil D. Perkins · Molecular and Cellular Biology · 1999 · 597 citations · Full text
ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant Melanoma
Natasha Y. Frank, Armen Margaryan, Ying Huang et al. · Cancer Research · 2005 · 571 citations · Full text
Medicine, Oncology, Pharmacology +16
p53 stabilization is decreased upon NFκB activation
Vinay Tergaonkar, Matthew P. Pando, Omid Vafa et al. · Cancer Cell · 2002 · 311 citations · Full text